yes i take peptides · shopping companion
CJC-1295
Category · For EnergyStatus · RUOCitations · 30Cancer Concern · WADA-banned
The verdict
Mostly no — the use case is narrow, and the marketing-clinic version (chronic stacked use in healthy adults) is the one we'd actively avoid.
By source — cost, legality, risk
- BrandNot availableNone — no FDA approvalNo FDA-approved CJC-1295.
- Compounded 503A pharmacy$150–$495/mo (typically bundled with ipamorelin)Rx · the dominant clinical channel (status contested pending formal FDA Cat 1 update)Lowest. Pharmacy-grade; most hormone clinics ship the CJC+ipamorelin stack.
- RUO research peptide$25–$60/moSold 'for research only'Highest. Large supply; CJC-1295-with-DAC vs without (Mod GRF 1-29) is sometimes interchanged at the label.
- Gray-market raw$5–$20/moUnregulated overseas importSame upstream molecule as RUO. Crypto/Wise pay; one box lasts many months at typical dose.
Stop signals · abort if
- persistent severe carpal-tunnel symptoms
- new or worsening hyperglycemia
- IGF-1 rising above age-appropriate range
- any new mass, lump, or unexplained pain
- new vision changes (retinopathy concern)
- chest pain or persistent palpitations
Sources · top 5 of 30
- 01Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism. 2006;91(3):799-805. PMID: 16352683.
- 02Van Hout MC, et al. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Substance use & misuse. 2016;51(1):73-84. PMID: 26771670.
- 03Rahman OF, et al. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2026;10(1). PMID: 41490200.
- 04Timms M, et al. A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS. Drug testing and analysis. 2019;11(8):1248-1257. PMID: 30938069.
- 05Mayfield CK, et al. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. The American journal of sports medicine. 2026;54(1):223-229. PMID: 41476424.